Abstract
Warfarin is the most widely used anticoagulant drug for treatment of patients with cardiovascular disease, especially those with prosthetic valves and atrial fibrillation. Despite its efficacy there is a management problem when it comes from the reduction of thrombotic events without creating an increased risk of bleeding. Maintaining the effectiveness and safety of warfarin therapy is ex…